Recruiting now—Ages 18 Years and up

Genomic Risk in Retroperitoneal Sarcoma

Sponsor: Fox Chase Cancer Center · NCT06436846 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Retroperitoneal LiposarcomaSoft Tissue Sarcoma

What it tests

Biospecimen sample collection during standard-of-care surgeryother

Where it's running1 site

Fox Chase Cancer Center
Philadelphia, Pennsylvania 19111
Recruiting now
- Anthony Villano, MD(contact)215-728-3686 [email protected]
- Margaret vonMehren, MD(sub investigator)
- Andres Correa, MD(sub investigator)
- Jeffrey Farma, MD, FACS(sub investigator)
- Stephanie Greco, MD, FACS(sub investigator)
- Alexander Kutikov, MD, FACS(sub investigator)
- Sanjay Reddy, MD, FACS(sub investigator)
- Lori Rink, PhD(sub investigator)
- Marc Smaldone, MD, MSHP, FACS(sub investigator)
- Robert Uzzo, MD, MBA, FACS(sub investigator)
- Rosalia Viterbo, MD, FACS(sub investigator)
- Shuanzeng Wei, MD, PhD(sub investigator)
- Johnathan Whetstine, PhD(sub investigator)
- Margaret von Mehren, MD(sub investigator)

See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Adult patients (age ≥18 years).
* Histologically confirmed retroperitoneal liposarcoma via preoperative biopsy, or cross-sectional imaging suspicious for liposarcoma with planned surgical resection
* Will be undergoing surgical resection for treatment of primary or recurrent disease
* Have provided informed consent to participate in this study

Exclusion Criteria:

• Prior surgical anatomy which makes sampling of remote areas of the retroperitoneum technically impossible or clinically undesirable for safety reasons

Updated 2024-05-31 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.